Can Hemicrania Continua Occur With Migraine Attacks?

Yes. It is entirely possible to have both hemicrania continua (HC) and migraine at the same time ^[1][2]. In fact, distinguishing between the two can be one of the biggest challenges in headache medicine because a severe spike in HC pain can look exactly like a severe migraine attack.

Understanding how these two conditions overlap—and how they differ—is essential for getting the right diagnosis and building a safe, effective treatment plan. Having symptoms of both can be confusing, but experiencing migraine-like symptoms during an HC flare does not mean you have been misdiagnosed, nor does it necessarily mean you have two separate conditions.

Why They Are So Easily Confused

During an active phase of hemicrania continua, the pain intensity can spike significantly (an exacerbation). During these flares, many people experience classic migraine-like symptoms, including nausea, vomiting, and sensitivity to light (photophobia) and sound (phonophobia) ^[3][4].

Because of this overlap, up to 70% of people with HC experience migraine-like features during their severe pain flares ^[5][6]. Additionally, both HC and migraine can cause cranial autonomic symptoms—such as eye redness, tearing, nasal congestion, a runny nose, or a drooping eyelid on the painful side ^[7][8]. Nausea or light sensitivity alone during a spike does not establish a separate migraine diagnosis; a separate migraine diagnosis requires a distinct pattern of independent attacks ^[3].

How to Tell the Difference

The most important clue is the longitudinal pattern of your pain over time, rather than just the symptoms present during a severe spike ^[9][10].

• The Temporal Pattern: Hemicrania continua is classically characterized by a persistent, strictly one-sided (side-locked) background pain that never entirely goes away during its active phase ^[9][3]. Migraine is traditionally a disorder of discrete, separate attacks. While chronic migraine can be continuous and occur on most or all days without pain-free periods, its diagnosis is defined by the frequency of headache days and migraine-feature days rather than a strictly side-locked continuous baseline ^[11][12].
• The Indomethacin Trial: A dramatic, sustained response to a prescription nonsteroidal anti-inflammatory drug (NSAID) called indomethacin is a required diagnostic feature of HC ^[4][13]. However, this test must be prescribed and monitored by a clinician. Indomethacin can relieve some migraine attacks, so a response is not a perfectly specific stand-alone confirmation. It requires an adequate therapeutic dose and duration to properly assess if the baseline pain disappears ^[13][14].
• Response to Migraine Medications: Medications designed to stop a migraine attack, such as triptans, do not reliably eliminate the continuous baseline pain of hemicrania continua ^[15]. They may, however, help treat a coexisting, separate migraine attack.

Comparison at a Glance

⚠️ URGENT SAFETY WARNING (Red Flags)
Always seek immediate medical evaluation if you experience a “worst of your life” headache, new neurological deficits (weakness, numbness, trouble speaking), fever with a stiff neck, sudden vision loss, or a rapid change in your established headache pattern. A clinician should evaluate any continuous one-sided headache to rule out secondary causes (like vascular issues) using imaging such as an MRI ^[16][17].

Keeping an Effective Diary

If you are trying to untangle these diagnoses, a highly specific headache diary is your best tool. Track the following to help your doctor reconstruct your headache pattern:

• Baseline vs. Flares: Note whether you have a continuous background pain, and separately record the start time, stop time, and duration of severe spikes ^[10].
• Side of Pain: Record if the pain is strictly locked to one side or if it ever switches sides.
• Pain-Free Periods: Document if you ever have a day (or even hours) with absolutely zero head pain.
• Accompanying Symptoms: Note if tearing, drooping eyelids, or restlessness occur specifically during the pain spikes ^[7].

Coordinating Treatment and Medication Safety

Treating coexisting HC and migraine requires careful coordination, as the treatments for one can complicate the other.

Indomethacin Safety Risks: HC is primarily managed with scheduled daily doses of indomethacin ^[16]. Long-term use of this NSAID carries significant risks, including gastrointestinal bleeding or ulcers, kidney injury, elevated blood pressure, and cardiovascular complications ^[18][19]. Your doctor may prescribe a stomach-protecting medication (like a proton pump inhibitor) to reduce upper-GI risks, but this does not eliminate all risks or protect the kidneys and heart ^[19][20]. Individualized monitoring of blood pressure and kidney function is essential ^[20][21]. Seek immediate help if you experience black/tarry stools, vomit blood, chest pain, or markedly reduced urine output.

Avoiding Medication Overuse Headache (MOH): Patients with frequent headaches are at risk for MOH. Formal diagnosis of MOH requires having a headache on at least 15 days per month, alongside the regular overuse of acute headache medications for more than 3 months ^[22][23]. The overuse thresholds vary by medication class: usually at least 10 days per month for triptans, opioids, or combination analgesics, and at least 15 days per month for simple NSAIDs or acetaminophen ^[23][24]. Because scheduled indomethacin is a disease-specific daily treatment for HC, it is generally categorized differently than acute rescue meds. However, it still adds to cumulative NSAID toxicity. Your clinician must help you classify and track all medication use to prevent MOH ^[22][23].

Preventative Alternatives: If indomethacin is poorly tolerated, or if you need to treat coexisting chronic migraine, your doctor might discuss other preventatives. OnabotulinumtoxinA (Botox) is an established, evidence-based preventive protocol for chronic migraine. For hemicrania continua, however, it is considered an off-label treatment with only limited, low-quality evidence from small reports suggesting it might reduce symptom frequency ^[25]. It is not a standard first-line substitute for indomethacin.